New York State Common Retirement Fund
AVIR icon

New York State Common Retirement Fund’s Atea Pharmaceuticals AVIR Stock Holding History

New York State Common Retirement Fund’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Hold
16,346
– – ﹤0.01% 2824
2026
Q1 		$87.9K Hold
16,346
– – ﹤0.01% 2584
2025
Q4 		$58.4K Hold
16,346
– – ﹤0.01% 2861
2025
Q3 		$47.4K Hold
16,346
– – ﹤0.01% 2968
2025
Q2 		$58.8K Hold
16,346
– – ﹤0.01% 2896
2025
Q1 		$48.9K Hold
16,346
– – ﹤0.01% 2784
2024
Q4 		$54.8K Hold
16,346
– – ﹤0.01% 2833
2024
Q3 		$54.8K Hold
16,346
– – ﹤0.01% 2830
2024
Q2 		$54.1K Buy
16,346
+54
+0.3% +$201 ﹤0.01% 3065
2024
Q1 		$65.8K Sell
16,292
-53
-0.3% -$207 ﹤0.01% 2895
2023
Q4 		$49.9K Sell
16,345
-166
-1% -$503 ﹤0.01% 2998
2023
Q3 		$49.5K Buy
16,511
+207
+1% +$704 ﹤0.01% 3026
2023
Q2 		$61K Sell
16,304
-73
-0.4% -$273 ﹤0.01% 3088
2023
Q1 		$54.9K Sell
16,377
-29,900
-65% -$121K ﹤0.01% 2973
2022
Q4 		$223K Sell
46,277
-13
-0% -$66 ﹤0.01% 2684
2022
Q3 		$263K Buy
46,290
+241
+0.5% +$1.84K ﹤0.01% 2647
2022
Q2 		$327K Buy
46,049
+6,599
+17% +$45K ﹤0.01% 2555
2022
Q1 		$285K Sell
39,450
-7,037
-15% -$47.8K ﹤0.01% 2664
2021
Q4 		$416K Sell
46,487
-188
-0.4% -$2.93K ﹤0.01% 2530
2021
Q3 		$1.64M Sell
46,675
-8,786
-16% -$244K ﹤0.01% 1866
2021
Q2 		$1.19M Buy
55,461
+41,661
+302% +$1.25M ﹤0.01% 2143
2021
Q1 		$852K Buy
13,800
+2,500
+22% +$169K ﹤0.01% 2191
2020
Q4 		$472K Buy
+11,300
New +$364K ﹤0.01% 2383

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

New York State Common Retirement Fund's AVIR Position: Q2 2026 in Review

New York State Common Retirement Fund held its Atea Pharmaceuticals (AVIR) position steady in Q2 2026 at 16,346 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

New York State Common Retirement Fund first reported a position in AVIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.64M in Q3 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • New York State Common Retirement Fund held 16,346 shares of Atea Pharmaceuticals worth $76K as of Q2 2026.
  • New York State Common Retirement Fund left its Atea Pharmaceuticals share count unchanged in Q2 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2824 holding.
  • New York State Common Retirement Fund first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • New York State Common Retirement Fund's Atea Pharmaceuticals position peaked at $1.64M in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.